The Bottom Line cover image

Blockbuster drugs

The Bottom Line

00:00

Introduction

Exploring the development and success of Novo Nordisk's blockbuster drugs targeting type 2 diabetes and obesity, and the challenges and opportunities in the pharmaceutical industry.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app